Ketamine Augmentation of ECT in Treatment-Resistant Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ketamine Augmentation of ECT in Treatment-Resistant Depression — Stella

Home/Major Depressive Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Major Depressive Disorder trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Italy

IRCCS Ospedale San Raffaele Turro, Milan

Key details

Phase

Large-scale testing

Sponsor

Università Vita-Salute San Raffaele

Enrollment target

~30 participants

Started

July 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.